Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
FTC wins case blocking Edwards' $945M JenaValve takeover
After a six-month battle, Edwards has been forced to walk away from its nearly $1 billion takeover attempt of heart implant developer JenaValve.
Ben Adams
Jan 12, 2026 8:15am
BrainSpace gets FDA clearance for brain fluid management system
Jan 6, 2026 4:05pm
Tela Bio sues BD over hernia mesh monopoly claims
Dec 23, 2025 12:22pm
Edwards nets FDA approval for Sapien M3 mitral valve replacement
Dec 23, 2025 11:00am
Abbott's Volt pulsed field ablation system scores FDA approval
Dec 22, 2025 11:48am
Editor's corner: Fierce Medtech's top 10 stories of 2025
Dec 22, 2025 10:30am
